Literature DB >> 32124627

Neuroenhancing Substances Use, Exam Anxiety and Academic Performance in Bosnian-Herzegovinian First-Year University Students.

Jasna Kusturica1, Ajša Hajdarević2, Haris Nikšić3, Amira Skopljak4, Zana Tafi5, Aida Kulo6.   

Abstract

OBJECTIVE: The aim of this study was to assess the relationship between the use of neuroenhancing substances, exam anxiety and academic performance among first-year Bosnian-Herzegovinian (BH) university students.
METHODS: In a cross-sectional study, an ad hoc questionnaire was delivered to a sample of BH first-year university students. The following data were collected: socio-demographic features, consumption of neuroenchancing substances, the Westside Test Anxiety Scale (WTAS) and academic performance.
RESULTS: A total of 214 students were included. Consumption of lifestyle substances, coffee, energy drinks, nicotine, alcohol, and marijuana, for the purpose of neuroenhancement increased during the week before the exams. OTC cognitive enhancer use was reported by 31.0%, and of benzodiazepines by 1.5% of students. No psycostimulants were used. A high to extremely high exam WTAS score was reported in 38.3% students. The exam WTAS score was positively correlated with consumption of coffee (rho=0.31; P<0.001), energy drinks (rho=0.18; P=0.009), and nicotine (rho=0.22; P=0.001), and negatively correlated with last exam grade (rho=-0.33; P<0.001). The exam WTAS score was a significant independent predictor (OR=0.55; 95% CI 0.31 to 0.97, P=0.039) for self-assessed academic performance. Self-assessed academic performance was positively correlated with last exam grade (rho=0.15; P=0.043).
CONCLUSIONS: Although first-year BH university students do not seem to use either prescription or illicit psycostimulants, the consumption of nicotine, alcohol, and marijuana is worrying. However, the consumption of these neuroenhancing substances seems not to be related to better self-assessed academic performance. Finally, exam anxiety seems to be a significant problem among BH first-year university students.
Copyright © 2019 by Academy of Sciences and Arts of Bosnia and Herzegovina.

Entities:  

Keywords:  Academic Performance; Anxiety; Lifestyle Drugs; Performance-Enhancing Substances; Psycostimulants

Year:  2019        PMID: 32124627     DOI: 10.5644/ama2006-124.269

Source DB:  PubMed          Journal:  Acta Med Acad        ISSN: 1840-1848


  4 in total

Review 1.  Non-invasive brain stimulation and neuroenhancement.

Authors:  Andrea Antal; Bruce Luber; Anna-Katharine Brem; Marom Bikson; Andre R Brunoni; Roi Cohen Kadosh; Veljko Dubljević; Shirley Fecteau; Florinda Ferreri; Agnes Flöel; Mark Hallett; Roy H Hamilton; Christoph S Herrmann; Michal Lavidor; Collen Loo; Caroline Lustenberger; Sergio Machado; Carlo Miniussi; Vera Moliadze; Michael A Nitsche; Simone Rossi; Paolo M Rossini; Emiliano Santarnecchi; Margitta Seeck; Gregor Thut; Zsolt Turi; Yoshikazu Ugawa; Ganesan Venkatasubramanian; Nicole Wenderoth; Anna Wexler; Ulf Ziemann; Walter Paulus
Journal:  Clin Neurophysiol Pract       Date:  2022-05-25

2.  Neuroenhancement: State of the Art and Future Perspectives.

Authors:  Donatella Marazziti; Maria Teresa Avella; Tea Ivaldi; Stefania Palermo; Lucia Massa; Alessandra Della Vecchia; Lucia Basile; Federico Mucci
Journal:  Clin Neuropsychiatry       Date:  2021-06

3.  The Prevalence of Pharmacological Neuroenhancement Among University Students Before and During the COVID-19-Pandemic: Results of Three Consecutive Cross-Sectional Survey Studies in Germany.

Authors:  Pavel Dietz; Antonia M Werner; Jennifer L Reichel; Markus Schäfer; Lina M Mülder; Manfred Beutel; Perikles Simon; Stephan Letzel; Sebastian Heller
Journal:  Front Public Health       Date:  2022-03-24

4.  Potential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germany.

Authors:  Sebastian Heller; Ana Nanette Tibubos; Thilo A Hoff; Antonia M Werner; Jennifer L Reichel; Lina M Mülder; Markus Schäfer; Daniel Pfirrmann; Birgit Stark; Thomas Rigotti; Perikles Simon; Manfred E Beutel; Stephan Letzel; Pavel Dietz
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.